Canada · Delayed Price · Currency is CAD Lassonde Industries Earnings Call Transcripts
Fiscal Year 2026
-
Operating profit rose 22% despite lower sales, driven by pricing discipline and cost alignment. National brands gained share, while private label faced headwinds. Guidance for CAD 3 billion in 2026 is maintained, with no volume boost expected from the new facility this year.
Fiscal Year 2025
-
Record sales and profitability were achieved in 2025, with strong margin expansion and market share gains across all divisions. The outlook for 2026 targets CAD 3 billion in sales, supported by innovation, disciplined pricing, and capacity investments.
-
Q3 2025 saw 8.3% sales growth and a 23% rise in operating profit, driven by pricing and improved private label mix. Full-year sales are expected to rise over 10%, with commodity volatility and trade uncertainty as key risks. Leverage and cash flow improved.
-
Record sales and profitability were achieved in 2024, driven by growth across all divisions and a major U.S. acquisition. Strategic investments and leadership changes position the company for continued North American expansion, while risks from commodity prices and trade remain under close watch.
-
Sales grew 22.8% to CAD 700 million, driven by market share gains and the Summer Garden acquisition. Adjusted EBITDA rose 36%, and the company expects 10% sales growth in 2025, while remaining cautious amid commodity volatility and increased U.S. promotions.
Fiscal Year 2024
-
Record 2024 results with sales over CAD 2.6B and strong EBITDA growth, driven by U.S. volume gains, Canadian pricing, and the Summer Garden acquisition. 2025 outlook targets 10% sales growth, with margin recovery expected after Q1 cost pressures and continued investment in U.S. expansion.
-
Q3 2024 saw strong sales and profit growth, driven by volume gains, efficiency improvements, and the Summer Garden acquisition. Major U.S. investments and ongoing innovation support a positive outlook, despite commodity cost pressures and global trade uncertainties.
-
Q2 saw 7.8% sales growth and 21% higher operating profit, led by U.S. volume gains and efficiency improvements. The North Carolina expansion and Summer Garden acquisition support future growth, with 2024 sales guidance raised to mid- to high-single digits.
-
The acquisition nearly doubles specialty food presence and expands U.S. reach, adding premium and health-oriented brands with strong growth potential. The $235M deal is accretive to margins and EPS, with synergies and integration investments expected to drive further value.